Empelvic Launches in Singapore at the Singapore International Physiotherapy Congress (SIPC) 2024

July 2024

The Empelvic Cushion: A Simple, Non-Invasive Solution for Pelvic Health Challenges

Singapore, 13th July 2024 – Owen Mumford proudly introduced the Empelvic cushion to the Singapore’s healthcare community at the Singapore International Physiotherapy Congress (SIPC) 2024, organized by the Singapore Physiotherapy Association, where Owen Mumford was honored to be the bronze sponsor. Held from 12th to 14th July under the theme "Advancing the Frontiers of Physiotherapy: Towards a Healthier SG," the event attracted over 400 physiotherapists and healthcare experts, showcasing the latest advancements in physiotherapy. Singapore serves as the launch pad for Empelvic in the Asia-Pacific region, bringing innovative pelvic health solutions to a broader audience.


Distributed in Singapore by Joyson Pte Ltd, the Empelvic cushion is an innovative training tool designed to support individuals managing pelvic health conditions such as vaginismus, stress incontinence, and postpartum pelvic floor dysfunction. Its launch signifies a significant step in enhancing pelvic health solutions for Singapore’s physiotherapists and their patients.


A Simple Solution for Complex Challenges
Pelvic health conditions affect millions globally, yet finding effective, non-invasive treatment options remains a challenge. In Asia, where pelvic floor dysfunction (PFD) is often considered taboo or embarrassing, at-home training is a crucial treatment option. However, seeking guidance from a physiotherapist is still recommended, and there is a pressing need to broaden the accessibility of these treatments.
The Empelvic cushion bridges this gap by helping users reconnect with their pelvic floor muscles—a critical first step in addressing many pelvic health concerns.


Physiotherapists frequently observe that patients with conditions like vaginismus or stress incontinence may struggle to identify or relax their pelvic floor muscles. The Empelvic cushion provides tactile feedback, enabling users to locate, relax, and strengthen these muscles through guided relaxation and breathing techniques. This tool empowers physiotherapists to guide patients during in-clinic sessions while supporting continued progress with at-home use.


Empelvic: Redefining Pelvic Health Therapy
The Empelvic cushion’s non-invasive, ergonomic design offers a user-friendly approach to addressing pelvic health issues. When users sit on the cushion, targeted pressure is applied to the pelvic floor, promoting muscle awareness and engagement. This unique functionality is particularly beneficial for:
•    Strengthening muscles to manage conditions such as urinary incontinence.
•    Relaxing hypertonic pelvic floors, including those affected by vaginismus.
•    Supporting antenatal preparation and postpartum recovery.
•    Alleviate erectile dysfunction.


At SIPC 2024, physiotherapists explored the cushion’s versatility in clinical and home-care settings. From postpartum recovery programs to individual therapy plans, the Empelvic cushion stands out as an accessible, effective tool for addressing diverse pelvic health needs.


Advancing Accessibility in Pelvic Health
The Singapore launch of the Empelvic cushion marks an important milestone in Owen Mumford’s commitment to advancing pelvic health solutions. By partnering with Joyson Pte Ltd, physiotherapists can now easily incorporate Empelvic into their practice, ensuring patients have access to seamless, effective care both in the clinic and at home.


About Empelvic
Since its debut in Denmark in 2017, the Empelvic cushion has empowered over 50,000 users worldwide. It received the prestigious Danish Design Award in the "Healthy Life" category in 2020.
Designed for both men and women, the Empelvic cushion promotes relaxation, awareness, and gentle strengthening of the pelvic floor muscles. Its non-invasive, sustainable design provides an effective solution for treating or preventing pelvic health conditions.
For more information, visit Empelvic.